An internal memo circulated at EMI, Radiohead's former record label, and obtained by Forbes.com, demonstrates the album's tectonic effects on the music industry.
The new studies, being published Tuesday in the Annals of Internal Medicine, provide a detailedlook at the extent of off-label use and associated risks and benefits.